The Solute Carrier MFSD1 Decreases the Activation Status of β1 Integrin and Thus Tumor MetastasisMarko Roblek, Daria E. Siekhaus|Frontiers in Oncology|2022Cited by 7
The solute carrier MFSD1 decreases β1 integrin’s activation status and thus tumor metastasisMarko Roblek, Daria E. Siekhaus|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 0